| 1.0501 0.06 (6.07%) | 01-29 15:59 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
ReWalk Robotics Ltd., an Israeli medical technology firm, was founded in 2001 and is headquartered in Yokneam Ilit. The company specializes in the creation and market introduction of robotic exoskeletons. These advanced devices are engineered to support individuals confronting mobility challenges or various other medical conditions across major global markets including the United States, Europe, the Asia-Pacific region, and Africa. Its product line features the ReWalk Personal and ReWalk Rehabilitation systems, designed for daily assistance for paraplegic individuals with spinal cord injuries, enabling their use both at home and within their communities. For clinical rehabilitation of stroke patients with lower limb disabilities, ReStore provides a soft exo-suit. Additionally, ReWalk offers the MyoCycle and MediTouch tutor, biofeedback tools facilitating movement therapy in either home or clinical environments. ReWalk Robotics distributes its innovative solutions directly to diverse clients, including third-party payers, rehabilitation centers and other institutions, and individual users. It also leverages third-party distributors to broaden its reach. The company operated previously under the name Argo Medical Technologies Ltd.
Mon, 25 Nov 2024
ReWalk Robotics Ltd (NASDAQ: RWLK) - Share Price - intelligentinvestor.com.au
Mon, 29 Jan 2024
ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward - Yahoo Finance
Thu, 11 Jan 2024
ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17 - GlobeNewswire
Wed, 23 Nov 2022
13 Best Robotics Stocks To Buy Now - Yahoo Finance
Fri, 20 Sep 2019
UPnRIDE standing wheelchair receives FDA clearance - Globes - Israel Business News
Tue, 04 Jun 2019
FDA Issues Clearance for the ReStore™ Exo-Suit, the First Soft Robotic System for Stroke Therapy - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |